Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A comprehensive map of the influenza A virus replication cycle.

Matsuoka Y, Matsumae H, Katoh M, Eisfeld AJ, Neumann G, Hase T, Ghosh S, Shoemaker JE, Lopes TJ, Watanabe T, Watanabe S, Fukuyama S, Kitano H, Kawaoka Y.

BMC Syst Biol. 2013 Oct 2;7:97. doi: 10.1186/1752-0509-7-97.

2.

Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals.

Heldt FS, Frensing T, Pflugmacher A, Gröpler R, Peschel B, Reichl U.

PLoS Comput Biol. 2013;9(11):e1003372. doi: 10.1371/journal.pcbi.1003372. Epub 2013 Nov 21.

3.

Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.

Lee SM, Yen HL.

Antiviral Res. 2012 Dec;96(3):391-404. doi: 10.1016/j.antiviral.2012.09.013. Epub 2012 Sep 26. Review.

PMID:
23022351
4.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

5.
6.

Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.

Tawaratsumida K, Phan V, Hrincius ER, High AA, Webby R, Redecke V, Häcker H.

J Virol. 2014 Aug;88(16):9038-48. doi: 10.1128/JVI.00830-14. Epub 2014 Jun 4.

7.

Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.

Yan D, Weisshaar M, Lamb K, Chung HK, Lin MZ, Plemper RK.

Biochemistry. 2015 Sep 15;54(36):5589-604. doi: 10.1021/acs.biochem.5b00623. Epub 2015 Sep 1.

8.

Exploration of binary virus-host interactions using an infectious protein complementation assay.

Munier S, Rolland T, Diot C, Jacob Y, Naffakh N.

Mol Cell Proteomics. 2013 Oct;12(10):2845-55. doi: 10.1074/mcp.M113.028688. Epub 2013 Jul 1.

9.

Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Londrigan SL, Short KR, Ma J, Gillespie L, Rockman SP, Brooks AG, Reading PC.

J Virol. 2015 Dec;89(24):12319-29. doi: 10.1128/JVI.01455-15. Epub 2015 Sep 30.

10.

High-content analysis of sequential events during the early phase of influenza A virus infection.

Banerjee I, Yamauchi Y, Helenius A, Horvath P.

PLoS One. 2013 Jul 12;8(7):e68450. doi: 10.1371/journal.pone.0068450. Print 2013.

11.

Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.

Shim JM, Kim J, Tenson T, Min JY, Kainov DE.

Viruses. 2017 Aug 12;9(8). pii: E223. doi: 10.3390/v9080223. Review.

12.

A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.

Hsu SF, Su WC, Jeng KS, Lai MM.

J Virol. 2015 Apr;89(7):3671-82. doi: 10.1128/JVI.03610-14. Epub 2015 Jan 14.

13.

Payao: a community platform for SBML pathway model curation.

Matsuoka Y, Ghosh S, Kikuchi N, Kitano H.

Bioinformatics. 2010 May 15;26(10):1381-3. doi: 10.1093/bioinformatics/btq143. Epub 2010 Apr 5.

14.

Dynamics of influenza virus and human host interactions during infection and replication cycle.

Madrahimov A, Helikar T, Kowal B, Lu G, Rogers J.

Bull Math Biol. 2013 Jun;75(6):988-1011. doi: 10.1007/s11538-012-9777-2. Epub 2012 Oct 19.

PMID:
23081726
15.

New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides.

Wu W, Lin D, Shen X, Li F, Fang Y, Li K, Xun T, Yang G, Yang J, Liu S, He J.

PLoS One. 2015 Sep 18;10(9):e0138426. doi: 10.1371/journal.pone.0138426. eCollection 2015.

16.

A systematic view on influenza induced host shutoff.

Bercovich-Kinori A, Tai J, Gelbart IA, Shitrit A, Ben-Moshe S, Drori Y, Itzkovitz S, Mandelboim M, Stern-Ginossar N.

Elife. 2016 Aug 15;5. pii: e18311. doi: 10.7554/eLife.18311.

17.

Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes.

Edinger TO, Pohl MO, Yángüez E, Stertz S.

MBio. 2015 Jun 9;6(3):e00297. doi: 10.1128/mBio.00297-15.

18.

Prolidase is required for early trafficking events during influenza A virus entry.

Pohl MO, Edinger TO, Stertz S.

J Virol. 2014 Oct;88(19):11271-83. doi: 10.1128/JVI.00800-14. Epub 2014 Jul 16.

19.

AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease.

Mizuno S, Iijima R, Ogishima S, Kikuchi M, Matsuoka Y, Ghosh S, Miyamoto T, Miyashita A, Kuwano R, Tanaka H.

BMC Syst Biol. 2012 May 30;6:52. doi: 10.1186/1752-0509-6-52.

20.

Novel roles of focal adhesion kinase in cytoplasmic entry and replication of influenza A viruses.

Elbahesh H, Cline T, Baranovich T, Govorkova EA, Schultz-Cherry S, Russell CJ.

J Virol. 2014 Jun;88(12):6714-28. doi: 10.1128/JVI.00530-14. Epub 2014 Apr 2.

Supplemental Content

Support Center